Table of Content
1 Industrial Chain Overview
1.1 Flu Vaccine Industry
1.1.1 Overview
Figure Flu Vaccine Picture List
1.1.2 Characteristics of Flu Vaccine
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Ofvaccines
1.3.1 Fluzone/Vaxigrip
1.3.2 Anflu
1.3.3 FluMist
1.3.4 Fluarix
1.3.5 FluLaval
1.3.6 Fluvax/Afluria
1.3.7 Fluvirin
1.3.8 Others
1.4 Product List By Influenza Viruses
1.5 End-Use List
1.5.1 Demand in Pediatrics
1.5.2 Demand in Adults
1.6 Global Market Overview
1.6.1 Global Market Size and Forecast, 2017-2027
Figure Global Market Size and Forecast with Growth Rate, 2017-2027
1.6.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027
Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027
1.6.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027
Table Global Market Size and Forecast by Ofvaccines with Growth Rate, 2017-2027
Table Global Market Size and Forecast by Influenza Viruses with Growth Rate, 2017-2027
1.6.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027
Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD
2.1.2 Global Consumption
Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.2 North America
Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.3 South America
Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.4 Europe
Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.2 North America
Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD
Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.3 South America
Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD
Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.4 Europe
Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Production Amount List in 2021
3.2 Manufacturers List
3.2.1 AstraZeneca Overview
Table AstraZeneca Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Flu Vaccine Business Operation of AstraZeneca (Production Amount (Million USD), Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 CSL Limited Overview
Table CSL Limited Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Flu Vaccine Business Operation of CSL Limited (Production Amount (Million USD), Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 GSK Overview
Table GSK Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Flu Vaccine Business Operation of GSK (Production Amount (Million USD), Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Hualun Biologicalsamong Overview
Table Hualun Biologicalsamong Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Flu Vaccine Business Operation of Hualun Biologicalsamong (Production Amount (Million USD), Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 ID Biomedical Corporation Overview
Table ID Biomedical Corporation Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Flu Vaccine Business Operation of ID Biomedical Corporation (Production Amount (Million USD), Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Johnson & Johnson Overview
Table Johnson & Johnson Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Flu Vaccine Business Operation of Johnson & Johnson (Production Amount (Million USD), Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 MedImmune, LLC Overview
Table MedImmune, LLC Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Flu Vaccine Business Operation of MedImmune, LLC (Production Amount (Million USD), Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Mylan Overview
Table Mylan Overview List
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Flu Vaccine Business Operation of Mylan (Production Amount (Million USD), Cost, Gross Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Novartis Overview
Table Novartis Overview List
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Flu Vaccine Business Operation of Novartis (Production Amount (Million USD), Cost, Gross Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Pfizer Overview
Table Pfizer Overview List
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Flu Vaccine Business Operation of Pfizer (Production Amount (Million USD), Cost, Gross Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Protein Sciences Corporaton Overview
Table Protein Sciences Corporaton Overview List
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Flu Vaccine Business Operation of Protein Sciences Corporaton (Production Amount (Million USD), Cost, Gross Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Sanofi Pasteur Overview
Table Sanofi Pasteur Overview List
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Flu Vaccine Business Operation of Sanofi Pasteur (Production Amount (Million USD), Cost, Gross Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Serum Institute of India Overview
Table Serum Institute of India Overview List
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Flu Vaccine Business Operation of Serum Institute of India (Production Amount (Million USD), Cost, Gross Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Sinovac Biotech Overview
Table Sinovac Biotech Overview List
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Flu Vaccine Business Operation of Sinovac Biotech (Production Amount (Million USD), Cost, Gross Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2017-2021, in Million USD
Figure Global Competition Sketch Overview
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD
Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD
Figure Global Production Amount Share by Manufacturers in 2021, in Million USD
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD
5.2 Segment Subdivision by Ofvaccines
5.2.1 Market in Fluzone/Vaxigrip
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Fluzone/Vaxigrip, 2017-2021, in USD Million
5.2.1.2 Situation & Development
5.2.2 Market in Anflu
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Anflu, 2017-2021, in USD Million
5.2.2.2 Situation & Development
5.2.3 Market in FluMist
5.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in FluMist, 2017-2021, in USD Million
5.2.3.2 Situation & Development
5.2.4 Market in Fluarix
5.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Fluarix, 2017-2021, in USD Million
5.2.4.2 Situation & Development
5.2.5 Market in FluLaval
5.2.5.1 Market Size
Figure Global Market Amount and Growth Rate in FluLaval, 2017-2021, in USD Million
5.2.5.2 Situation & Development
5.2.6 Market in Fluvax/Afluria
5.2.6.1 Market Size
Figure Global Market Amount and Growth Rate in Fluvax/Afluria, 2017-2021, in USD Million
5.2.6.2 Situation & Development
5.2.7 Market in Fluvirin
5.2.7.1 Market Size
Figure Global Market Amount and Growth Rate in Fluvirin, 2017-2021, in USD Million
5.2.7.2 Situation & Development
5.2.8 Market in Others
5.2.8.1 Market Size
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million
5.2.8.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD
6.2 Segment Subdivision
6.2.1 Market in Pediatrics
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Pediatrics, 2017-2021, in USD Million
6.2.1.2 Situation & Development
6.2.2 Market in Adults
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Adults, 2017-2021, in USD Million
6.2.2.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2022-2027, in Million USD
7.2 Consumption Forecast
7.2.1 Product Type Forecast by Ofvaccines
Table Global Market Amount by Ofvaccines Segment 2022-2027, in Million USD
7.2.2 Product Type Forecast by Influenza Viruses
7.2.3 End-Use Forecast
Table Global Market Amount by End-Use Segment 2022-2027, in Million USD
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Flu Vaccine Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 Research Conclusion